
- Telehealth Visits
- Insurance plan information

Seung Ah Lee, MD
Plastic Surgery- Telehealth Visits
- Insurance plan information



Seung Ah Lee, MD
Plastic Surgery- Telehealth Visits
- Insurance plan information
On this page
About me
Dr. Seung Ah Lee is a plastic and reconstructive surgeon who specializes in cosmetic and complex surgeries, with a focus on breast reconstruction. She has expertise in advanced techniques, such as microsurgical free tissue transfers (replacing damaged tissue with healthy tissue from another part of the body), implant-based breast reconstruction methods, local tissue rearrangement to create symmetry in the cancer-affected breast, and fat grafting for the breast (using fat from another part of the body). She also performs reconstructive surgery for defects in the head, neck, torso, arms and legs, as well as peripheral nerves. She believes in empowering patients through education, offering the information they need to be fully involved in their health care journeys.
Lee earned her medical degree from the University of Missouri. She completed a residency in plastic and reconstructive surgery at the University of California, Irvine, followed by a fellowship in microsurgery at UCSF.
Education & training
Fellowship
- Microsurgery, UCSF Graduate Medical Education
Residency
- Plastic Surgery, University of California - Irvine Medical Center
Internship
- Plastic Surgery, University of California - Irvine Medical Center
Degree
- MD, University of Missouri at Columbia
My expertise
Specialties
Locations
Clinical Trials query: q=health_gateway_id_ss%3A%28%224701%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%224701%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Publication%22
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.